645 Followers on Owler
OverviewCompetitorsNews & Insights

Upsher-Smith Competitors or Alternatives

Upsher-Smith's top competitors include Saol Therapeutics, Supernus and Piramal Critical Care.

Unlock 23 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Upsher-Smith's company profile

Taku Nakaoka

Chairman & CEO

84/100
500 - 1,000
$0
$100M - 500M
  • $0
    $100M - 500M
  • 500 - 1,000
    $0
  • $100M - 500M
  • 84/100
  • 500 - 1,000
  • $0
  • $100M - 500M
View ProfileView
1
Upsher-Smith's Competitor - Saol Therapeutics logo

David Penake

CEO

70/100
100 - 250
$1M
$25M - 100M
  • $1M
    $25M - 100M
  • 100 - 250
    $1M
  • $25M - 100M
  • 70/100
  • 100 - 250
  • $1M
  • $25M - 100M
View ProfileView
2
Upsher-Smith's Competitor - Supernus logo

Jack A. Khattar

President & CEO

92/100
580
$897M
$661.8M
  • $897M
    $661.8M
  • 580
    $897M
  • $661.8M
  • 92/100
  • 580
  • $897M
  • $661.8M
View ProfileView
3
Upsher-Smith's Competitor - Piramal Critical Care logo

Peter DeYoung

CEO

85/100
1 - 25
- -
$5M - 25M
  • - -
    $5M - 25M
  • 1 - 25
    - -
  • $5M - 25M
  • 85/100
  • 1 - 25
  • - -
  • $5M - 25M
View ProfileView
4
Upsher-Smith's Competitor - Aprecia logo

Owen Murray

CEO

82/100
25 - 100
$226.8M
$5M - 25M
  • $226.8M
    $5M - 25M
  • 25 - 100
    $226.8M
  • $5M - 25M
  • 82/100
  • 25 - 100
  • $226.8M
  • $5M - 25M
View ProfileView
5
Upsher-Smith's Competitor - ASCEND Therapeutics logo

Nicholas Hart

President & CEO

81/100
25 - 100
- -
$5M - 25M
  • - -
    $5M - 25M
  • 25 - 100
    - -
  • $5M - 25M
  • 81/100
  • 25 - 100
  • - -
  • $5M - 25M
View ProfileView
Upsher-Smith's top 26 competitors are Saol Therapeutics, Supernus, Piramal Critical Care, Otsuka, Aprecia, ASCEND Therapeutics, Mylan, Ambrx, TEVA, rEVO Biologics, Duchesnay Inc., Lexicon, Sanofi, TruTag, Sandoz, Citeline, Cipla, Dr.Reddy's, Roche, AstraZeneca, Novartis, Sun Pharma, Orexigen Therapeutics, Inc., Galecto, Mallinckrodt and Marinus. Together they have raised over 33.2B between their estimated 601.5K employees. Upsher-Smith's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 11.4B. Upsher-Smith has 500 employees and is ranked 14th among it's top 10 competitors. The top 10 competitors average 22,294.

Upsher-Smith VS Saol Therapeutics

Saol Therapeutics is one of Upsher-Smith's top competitors. Saol Therapeutics is a Private company that was founded in Roswell, Georgia in 2015. Saol Therapeutics is in the Pharmaceuticals field. Saol Therapeutics has 400 fewer employees vs. Upsher-Smith.

Upsher-Smith VS Supernus

Supernus is perceived as one of Upsher-Smith's biggest rivals. Supernus was founded in 2005 in Rockville, Maryland. Supernus competes in the Pharmaceuticals industry. Supernus generates $300.8M more revenue than Upsher-Smith.

Upsher-Smith VS Piramal Critical Care

Piramal Critical Care is a top competitor of Upsher-Smith. Piramal Critical Care's headquarters is in Bethlehem, Pennsylvania, and was founded in 2002. Piramal Critical Care competes in the Pharmaceuticals field. Piramal Critical Care generates 1.39% of Upsher-Smith's revenue.

Looking for similar companies to Upsher-Smith?

Similar Companies

Pharmaceuticals companies in Twin Cities

See 71 companies 
Pharmaceuticals & Biotechnology companies in Twin Cities

See 167 companies 
Pharmaceuticals companies in Minnesota

See 84 companies 
Pharmaceuticals & Biotechnology companies in Minnesota

See 206 companies 
Pharmaceuticals companies with employees in 500-1.0K range

See 229 companies 
Companies in Twin Cities with revenue in $100-500M range

See 289 companies 
Pharmaceuticals companies with revenue in $100-500M range

See 298 companies 
Companies in Minnesota with revenue in $100-500M range

See 298 companies 
Pharmaceuticals & Biotechnology companies with employees in 500-1.0K range

See 447 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Upsher-Smith and Upsher-Smith's Competitors

March 31, 2025Pharmabiz
The US Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adu...
March 31, 2025FinanzNachrichten
LONDON (dpa-AFX) - British drug major AstraZeneca Plc.'s (AZN, AZN.L) Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant...
March 29, 2025Pharmabiz
The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of...

Frequently Asked Questions about Upsher-Smith

  1. Who are Upsher-Smith's top competitors?

    Upsher-Smith's top 3 competitors are Saol Therapeutics, Supernus, Piramal Critical Care.

  2. Who is similar to Upsher-Smith?

    Saol Therapeutics is the most similar to Upsher-Smith. Supernus and Piramal Critical Care are also similar to Upsher-Smith.

  1. Are Upsher-Smith and Saol Therapeutics competitors?

    Yes, Saol Therapeutics is one of Upsher-Smith’s top competitors.